These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 23702731

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinicopathologic study of 128 cases of T-lymphoblastic lymphoma/leukemia].
    Yu B, Du JR, Xie JL, Yu R, Zheng XD, Zhu H, Zhou XG.
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):452-7. PubMed ID: 21055173
    [Abstract] [Full Text] [Related]

  • 5. Clinicopathologic and prognostic features of TdT-negative pediatric B-lymphoblastic leukemia.
    Klairmont MM, Zhou Y, Cheng C, Pui CH, Jeha S, Gruber TA, Liu Y, Inaba H, Choi JK.
    Mod Pathol; 2021 Nov; 34(11):2050-2054. PubMed ID: 34148065
    [Abstract] [Full Text] [Related]

  • 6. Precursor B- or T-lymphoblastic lymphoma presenting with cutaneous involvement: a series of 13 cases including 7 cases of cutaneous T-lymphoblastic lymphoma.
    Lee WJ, Moon HR, Won CH, Chang SE, Choi JH, Moon KC, Lee MW.
    J Am Acad Dermatol; 2014 Feb; 70(2):318-25. PubMed ID: 24314877
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. TDT (-), KIT (+), CD34 (+), CD99 (+) precursor T lymphoblastic leukemia/lymphoma.
    Terada T.
    Int J Clin Exp Pathol; 2012 Feb; 5(2):167-70. PubMed ID: 22400079
    [Abstract] [Full Text] [Related]

  • 10. Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine.
    Morita K, Jain N, Kantarjian H, Takahashi K, Fang H, Konopleva M, El Hussein S, Wang F, Short NJ, Maiti A, Sasaki K, Garcia-Manero G, Konoplev S, Ravandi F, Khoury JD, Jabbour E.
    Am J Hematol; 2021 May 01; 96(5):589-598. PubMed ID: 33639000
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Diagnostic value of anti-terminal deoxynucleotidyl transferase antibody (TdT) in hematologic pathology].
    Valmary S, Danjoux M, Delsol G, Brousset P.
    Ann Pathol; 2005 Feb 01; 25(1):25-32. PubMed ID: 15981929
    [Abstract] [Full Text] [Related]

  • 13. [Outcome of 126 adolescent and adult T-cell acute leukemia/lymphoma patients and the prognostic significance of early T-cell precursor leukemia subtype].
    Liao HY, Sun ZY, Wang YX, Jin YM, Zhu HL, Jiang NG.
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jul 14; 40(7):561-567. PubMed ID: 32397018
    [Abstract] [Full Text] [Related]

  • 14. Early T-Cell Precursor Leukemia: A High-Risk Subtype of Acute Lymphoblastic Leukemia, Single Center Experience in Jordan.
    Halahleh K, Muradi I, Khalil MZ, Halahleh L, Sughayer M, Kamal N, Sultan I, Alrabi K.
    Clin Lymphoma Myeloma Leuk; 2023 Nov 14; 23(11):e411-e419. PubMed ID: 37730482
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Terminal Deoxynucleotidyl Transferase (TdT)-negative Lymphoblastic Leukemia in Pediatric Patients: Incidence and Clinical Significance.
    Yasmeen S, Rajkumar A, Grossman H, Szallasi A.
    Pediatr Dev Pathol; 2017 Nov 14; 20(6):463-468. PubMed ID: 29187045
    [Abstract] [Full Text] [Related]

  • 17. Terminal deoxynucleotidyl transferase-negative acute lymphoblastic leukemia.
    Faber J, Kantarjian H, Roberts MW, Keating M, Freireich E, Albitar M.
    Arch Pathol Lab Med; 2000 Jan 14; 124(1):92-7. PubMed ID: 10629138
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic implications of TdT expression in acute myeloid leukemia with an intermediate-risk karyotype.
    Saburi M, Ogata M, Satou T, Soga Y, Itani K, Kohno K, Kondo Y, Nakayama T.
    Int J Hematol; 2020 Jul 14; 112(1):17-23. PubMed ID: 32253665
    [Abstract] [Full Text] [Related]

  • 20. LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations.
    Brar N, Butzmann A, Kumar J, Peerani R, Morgan EA, Grigoriadis G, Kumar B, Tatarczuch RM, Warnke RA, Ohgami RS.
    Histopathology; 2020 Dec 14; 77(6):984-988. PubMed ID: 32526041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.